Cargando…

Retrospective Analysis of Clinical Outcomes in Patients with Immunoglobulin A Nephropathy and Persistent Hematuria Following Renin-Angiotensin System Blockade

BACKGROUND: Recent guidelines recommend that patients with immunoglobulin A nephropathy (IgAN) and proteinuria 0.5–1 g/d and >1 g/d be treated with long-term renin–angiotensin system blockade (RASB). This study investigated whether patients with IgAN and persistent hematuria, but without proteinu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Jingjing, Liu, Shao, Xu, Hui, Wang, Wei, Xie, Yanyun, Tang, Wenbin, Yuan, Qiongjing, Zheng, Li, Lin, Lizhen, Fu, Shuangshuang, Shen, Jinmei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International Scientific Literature, Inc. 2020
Materias:	Clinical Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7456162/ https://www.ncbi.nlm.nih.gov/pubmed/32822333 http://dx.doi.org/10.12659/MSM.922839

Ejemplares similares

Dual Blockade of the Renin-Angiotensin System in Diabetic Nephropathy
por: Ravid, Mordchai
Publicado: (2009)

Renin-Angiotensin-Aldosterone System Blockade in Diabetic Nephropathy. Present Evidences
por: Lozano-Maneiro, Luz, et al.
Publicado: (2015)

Emerging Therapies for Diabetic Nephropathy Patients: Beyond Blockade of the Renin-Angiotensin System
por: Tanios, Bassem Y., et al.
Publicado: (2012)

Effect of hematuria on the outcome of immunoglobulin A nephropathy with proteinuria
por: Iwasaki, Chihiro, et al.
Publicado: (2016)

Single versus dual blockade of the renin-angiotensin system in patients with IgA nephropathy
por: Lennartz, David Paul, et al.
Publicado: (2020)

You are what you Eat: Dietary Salt Intake and Renin Angiotensin Blockade in Diabetic Nephropathy
por: Charytan, David M., et al.
Publicado: (2012)

Use of low-dose sulodexide in IgA nephropathy patients on renin–angiotensin system blockades
por: Yang, Byeong Yun, et al.
Publicado: (2012)

Prominent hyperplasia of renin-producing juxtaglomerular apparatus after chronic and complete blockade of the renin-angiotensin system in adult IgA nephropathy
por: Abe, Michiaki, et al.
Publicado: (2015)

Cellular and metabolic effects of renin-angiotensin system blockade on glycogen storage disease type I nephropathy
por: Monteillet, Laure, et al.
Publicado: (2021)

Supportive Management of IgA Nephropathy With Renin-Angiotensin Blockade, the AIIMS Primary IgA Nephropathy Cohort (APPROACH) Study
por: Bagchi, Soumita, et al.
Publicado: (2021)

Renin–angiotensin system blockade for the risk of cancer and death
por: Shen, Jian, et al.
Publicado: (2016)

Management of proteinuria: blockade of the renin–angiotensin–aldosterone system
por: Athavale, Akshay, et al.
Publicado: (2020)

Left ventricular hypertrophy and renin-angiotensin system blockade
por: Cowan, Brett R., et al.
Publicado: (2009)

Renin–angiotensin system blockade in the COVID-19 pandemic
por: Cohen, Jordana B, et al.
Publicado: (2021)

Renal Kallikrein Activation and Renoprotection after Dual Blockade of Renin-Angiotensin System in Diet-Induced Diabetic Nephropathy
por: Zou, Xia, et al.
Publicado: (2015)

Association of acute tubular necrosis with gross hematuria in cirrhosis-related immunoglobulin A nephropathy
por: Soo Han, Jang, et al.
Publicado: (2013)

Dual Blockade of Renin Angiotensin System in Reducing the Early Changes of Diabetic Retinopathy and Nephropathy in a Diabetic Rat Model
por: Thangaraju, Pugazhenthan, et al.
Publicado: (2014)

Inhibition of (pro)renin Receptor Contributes to Renoprotective Effects of Angiotensin II Type 1 Receptor Blockade in Diabetic Nephropathy
por: Zhang, Lin, et al.
Publicado: (2017)

Cardiovascular Risk Reduction with Renin-Angiotensin Aldosterone System Blockade
por: Houston Miller, Nancy
Publicado: (2010)

Advances in the Renin-Angiotensin-Aldosterone System: Relevance to Diabetic Nephropathy
por: Koitka, Audrey, et al.
Publicado: (2008)

Dual Blockade of the Renin-angiotensin-aldosterone System in Type 2 Diabetic Kidney Disease
por: Feng, Yan-Huan, et al.
Publicado: (2016)

Possible beneficial association between renin-angiotensin-aldosterone-system blockade usage and graft prognosis in allograft IgA nephropathy: a retrospective cohort study
por: Park, Sehoon, et al.
Publicado: (2019)

Improvement of Sodium Status to Optimize the Efficacy of Renin-Angiotensin System Blockade
por: Laverman, Gozewijn D., et al.
Publicado: (2011)

Retarding the progression of chronic kidney disease with renin angiotensin system blockade
por: Limesh, M., et al.
Publicado: (2012)

Renin-Angiotensin System Blockade in Advanced Kidney Disease: Stop or Continue?
por: Burnier, Michel
Publicado: (2020)

Renin-Angiotensin System Blockade in COVID-19: Good, Bad, or Indifferent?
por: Bloch, Michael J.
Publicado: (2020)

Renin-Angiotensin System Blockade in Acute Myocardial Infarction: Is There a Winner?
por: Lee, Hak Seung, et al.
Publicado: (2020)

Risk of lung cancer and renin–angiotensin blockade: a concise review
por: Rachow, Tobias, et al.
Publicado: (2020)

The Effect of Renin-Angiotensin-Aldosterone System Blockade Medications on Contrast-Induced Nephropathy in Patients Undergoing Coronary Angiography: A Meta-Analysis
por: Wu, Zhijun, et al.
Publicado: (2015)

Renin-Angiotensin System Blockade Associated with Statin Improves Endothelial Function in Diabetics
por: Gismondi, Ronaldo Altenburg, et al.
Publicado: (2015)

The association of renin–angiotensin system blockades and pneumonia requiring admission in patients with COPD
por: Kim, Junghyun, et al.
Publicado: (2016)

Renin-Angiotensin System Blockade and Mortality in Patients With Hypertension and COVID-19 Infection
por: Salah, Husam M., et al.
Publicado: (2020)

Effect of Renin-Angiotensin System Blockade on Mortality in Korean Hypertensive Patients with Proteinuria
por: Oh, Hyung Jung, et al.
Publicado: (2019)

Oxidative Stress/Angiotensinogen/Renin-Angiotensin System Axis in Patients with Diabetic Nephropathy
por: Kamiyama, Masumi, et al.
Publicado: (2013)

Renal hemosiderosis presenting with acute kidney Injury and macroscopic hematuria in Immunoglobulin A nephropathy: a case report
por: Taguchi, Shinya, et al.
Publicado: (2021)

Retrospective clinical study of renin-angiotensin system blockers in lung cancer patients with hypertension
por: Wei, Jie, et al.
Publicado: (2019)

Renin-angiotensin system blockade on angiotensin-converting enzyme 2 and TMPRSS2 in human type II pneumocytes
por: Silva, Mauro G., et al.
Publicado: (2022)

Benefits of Renin-Angiotensin Blockade on Retinopathy in Type 1 Diabetes Vary With Glycemic Control
por: Harindhanavudhi, Tasma, et al.
Publicado: (2011)

Prognonstic impact of renin-angiotensin system blockade in localised upper-tract urothelial carcinoma
por: Tanaka, N, et al.
Publicado: (2012)

Efficacy and safety of dual blockade of the renin-angiotensin system: meta-analysis of randomised trials
por: Makani, Harikrishna, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_47ikha8rm3v0j9nfp2g2fioo64